Expression of PD-1 was increased after Vγ9Vδ2 T cell stimulation but pre-treatment of PD-L1 Daudi tumor cells with zoledronic acid was sufficient to render them susceptible to Vγ9Vδ2 T cell killing irrespective of PD-L expression (55). Here, CD274 is linked to neoplasm.